How Myoreval helps?

Myoreval significantly upregulates SIRTUINS & Nrf2 genes and significantly decreases risk factor of CVD within first 180 days of therapy.

MYOREVAL Upregulates SIRTUIN & Nrf2

1

MYOREVAL promotes reverse cholesterol transport. Sirtuins & Nrf2 genes activates LXR & FXR, and increases the expression of Apo-A1, Promoting HDL synthesis.

2

MYOREVAL decreases prevalence of myocardial infarction. Sirtuins & Nrf2 gene activation decreases MMP2 & prevents plaque rupture & degradation of collagen and elastin.

3

MYOREVAL improves vascular tone. Sirtuins & Nrf2 gene activation deacetylates eNOS , increases NO synthesis and promotes vasodilation.

4

MYOREVAL regulates rhythm of heart. Sirtuins & Nrf2 gene activation deacetylates SERCA-2a improves relaxation and contraction of cardiac muscles.

5

MYOREVAL regulates overall cardiac performance. Sirtuins & Nrf2 gene activation deacetylates PGC-1 alpha, improves contractability of heart.

6

MYOREVAL decreases cardiac hypertrophy. Sirtuin & Nrf2 gene activation regulates the kinases and decrease the cardiac hypertrophy.